SmartTRAK Life Sciences News and Analysis Blog

Natasha Weeks

13 years' experience in marketing and product development, including 5+ years at DePuy Synthes Trauma - most recently as Product Director at DePuy Synthes Trauma.

Healthy Growth: Q123 Trauma Market Recap

By Natasha Weeks on 7/24/23 9:28 AM

Strong returns in IM Nailing and a flurry of activity in the Pediatric space results in a healthy Q123 for the Trauma Market

The US Trauma Market grew +6.0% in Q123 fueled by new product adoption. While headwinds such as supply chain constraints, economic challenges and staffing shortages could darken the forecast, SmartTRAK expects the Trauma Market will not be as heavily impacted as its elective procedure counterparts and should continue to experience healthy growth through 2023 as many manufacturers note Q1 results are in line with pre-Covid historical trends.

Among the many topics covered in detail in SmartTRAK 's comprehensive Q123 Trauma Market Recap * are:

Complete Q123 Trauma Market Overview
SmartTRAK's Expert Market Analysis and Insights
All Trauma Companies' News, Revenues, Data, Charts and Market Shares
IM Nailing Closes the Quarter on High with Solid Returns
New Regulatory Clearances Propel the Pediatric Trauma Segment:
- OrthoPediatrics
- NuVasive Specialized Orthopedics, Inc.
- Wishbone Medical
Q123 Trauma Regulatory Highlights

During Q1, the Pediatric Trauma segment experienced a notable surge in regulatory clearances, indicating forthcoming product launches aimed at bolstering the segment's growth. These approvals signal ...

Read the entire Q123 Trauma Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Topics: Orthopedics Trauma Orthopedic Pediatrics

2 min read

New Products Propel Growth: Q422 Trauma Market Recap

By Natasha Weeks on 4/17/23 10:16 AM

New product introductions propelled growth for the Trauma segment during the fourth quarter.

Historically the top segments in the Trauma Market, Plates & Screws and IM Nails, didn’t disappoint in Q4 and fueled growth for the overall Trauma Market. During Q422, manufacturers specifically touted IM nailing and plating systems as revenue drivers. Top players emphasized the importance of offering robust plating and IM nailing portfolios to customers noting it was key for positioning strategies to compete in healthcare requests for proposals (RFPs) and tenders.

Among the many topics covered in detail in our comprehensive Q422 Trauma Market Recap* are:

Complete Q422 Trauma Market Overview and Highlights
SmartTRAK's Expert Market Analysis and Insights
All Company News, Revenues, Data, Charts and Shares
Plates & Screws and IM Nails Propel Growth for the Quarter
Globus Continues to Make Strides in Trauma Filling Out Product Portfolio
Q422 Trauma Market Regulatory Highlights

The number one trauma player, DePuy Synthes* (46.6% Q4 US Trauma market share) attributed Q422 and full-year 2022 growth to market recovery along with market adoption of new introductions such as ...

Read the entire Q422 Trauma Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares.*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

2 min read

New Products and Easier Comps Drive US Growth: Q322 Trauma Market Recap

By Natasha Weeks on 1/3/23 9:30 AM

Despite declining OUS results, the US Trauma Market experienced healthy growth attributed to adoption of new products.

While OUS results declined in Q322 due to foreign currency headwinds and China’s value-based pricing, the US drove the overall market through product penetration and easier comps due to the Q321 COVID waves that impacted procedural volumes last year. Companies posted healthy US growth, attributing new products for driving growth, with plans for additional launches in Q4 and 2023.

Among the many topics covered in detail in our comprehensive Q322 Trauma Market Recap* are:

Topics: Orthopedics Trauma

10 min read

What's New in Trauma and Extremities?

By Natasha Weeks on 12/5/22 10:12 AM

In the market for Trauma & Extremities, companies continue to innovate with new product introductions as well as a value-based care approach that promotes supporting clinical evidence for new and existing products showing their benefits to the patient and the hospital. Manufacturers are investing in solutions beyond implants to differentiate themselves and gain share in the Trauma & Extremities markets. SmartTRAK has observed a variety of strategies and solutions in the fast-paced hallux valgus segment as well as investment in deformity correction and periprosthetic solutions. The following is a sample of SmartTRAK's recent Trauma & Extremities news and developments from around the world, compiled, curated and posted in real-time by the expert analysts at SmartTRAK.

We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, financial data and competitor developments in the global Life Sciences industry. If you'd like to receive these expert insights daily, Contact Us to learn more. Our users think it's the perfect way to start their day.

New Products:

CAPTIVATE Cannulated Screw System* - Globus*

Globus announced the launch of the CAPTIVATE Headed Cannulated Screw System in diameters 2.5/3.0 mm, 3.5/4.0 mm, 4.5/5.5 mm. SmartTRAK reviewed the products at OTA with Globus as the Company fills out its Trauma & Extremities portfolio. LinkedIn
Stryker*

Stryker launched the Gamma4 System, the next-gen IM nail system from the IM Nail market leader (45.6% US share in 2021) according to SmartTRAK’s Financial Dashboard. The new system features a precision pin, redefined nail design and integrated instrument.

Topics: Orthopedics Trauma Extremities

1 min read

Trends and Advancements in Foot & Ankle: AOFAS 2022

By Natasha Weeks on 11/17/22 9:38 AM

SmartTRAK highlights new products and Company strategies to penetrate the Foot & Ankle space at AOFAS 2022

SmartTRAK identified several key themes and takeaways from the American Orthopaedic Foot & Ankle Society (AOFAS) 2022 meeting held recently in Quebec City, Canada. Manufacturers showcased product introductions with a continued focus on hallux valgus solutions and are investing in solutions beyond implants to differentiate themselves and gain share in the US Foot & Ankle Market.

Among the many topics covered in detail in the complete article, which can be downloaded here, are:

Small, Niche Players Attempt to Gain Share
- Globus Fills Out Trauma and Extremities Product Portfolios
- Enovis Showcases New Products and Gains Traction in F&A Space
Direct-To-Consumer Marketing Drives Growth in Hallux Valgus Market
- Treace Medical Outpaces Others
- Medartis Showcases New Products
- JNJ/DePuy/Synthes' Acquisition
- Paragon28 Focuses on the MIS Segment

To download the complete "AOFAS 2022: Trends and Advancements in Foot & Ankle" article by SmartTRAK's Natasha Weeks, Sr. Analyst, Trauma & Extremities, just click the button below.

Topics: Orthopedics Trauma Extremities

2 min read

Trends and Advancements in Trauma: OTA 2022

By Natasha Weeks on 11/14/22 11:34 AM

SmartTRAK highlights the latest trends and innovations at OTA 2022, with a focus on deformity correction and limb lengthening.

Our expert analysts focus in on the latest advancements, key trends and takeaways from the Orthopedic Trauma Association (OTA) meeting in Tampa, Florida held October 12–15, 2022. Major trauma manufacturers showcased innovation through new product introductions.

Stepping Outside of Internal Fixation

In the market for ring fixation devices, companies have been innovating beyond static frames and are developing dynamic, computer-assisted hexapod frames to treat bone fractures and deformity corrections. One of the challenges with hexapod frames is that they require manual strut adjustments, a process that is prone to patient and clinician error and can require up to 20 manual adjustments per day—a definite burden on the patient and caregiver ...

Topics: Top Story Trauma Extremities

2 min read

New Products Will Drive Growth: Q222 Trauma Market Recap

By Natasha Weeks on 9/19/22 9:24 AM

Quarterly growth stalled due to weather, supply chain and staffing, but the promise of new product introductions in H2 will return healthy growth to the Trauma Market.

The Q222 Trauma Market was impacted by several conditions that contributed to decelerating growth, such as a reduced demand for trauma-related devices, supply chain challenges and facility staffing hurdles. The WW Trauma Market growth slowed sequentially in Q2, down compared to Q122’s growth. The US Trauma Market fared a bit better than WW results, but also experienced a sequential slump compared to Q122. For the first half of 2022, the US Trauma Market was up +3.5% YTD growth compared to H121.

Among the many topics covered in detail in our comprehensive Q222 Trauma Market Recap* are:

Complete Q222 Trauma Overview and Highlights
SmartTRAK's Expert Analysis and Insights
All Company News including Revenues, Data, Charts and Shares
Mergers & Acquisitions
Q222 Trauma Regulatory Highlights

Topics: Trauma

2 min read

Healthy Growth w/ Mixed Results: Q122 Trauma Market Recap

By Natasha Weeks on 7/28/22 9:30 AM

Despite mixed results from Trauma players, the segment experienced healthy growth as mergers and acquisitions were plentiful and regulatory clearances show promise of future new product introductions.

Topics: Orthopedics Trauma

2 min read

New Products Offset COVID Headwinds: Q421/FY21 Trauma Market Recap

By Natasha Weeks on 3/31/22 9:30 AM

New product introductions offset slightly weaker Q4 results due to COVID-19 headwinds and international pressure.

While the Trauma segment was not impacted as heavily due to COVID-19 headwinds, companies that play within the space were impacted by deferrals of elective surgeries such as limb restoration. Long bone trauma volumes remained healthy as players cited new product introductions as growth drivers for the segment.

Among the many topics covered in detail in our comprehensive Q421/FY21 Trauma Market Recap* are:

Topics: Orthopedics Trauma

2 min read

Riding the Wave of Healthy Growth: Q321 Trauma Market Recap

By Natasha Weeks on 12/27/21 4:01 PM

Trauma market continues to ride the wave of healthy growth with positive returns for current players and new players start to stir the waters

Trauma players rode the wave of another quarter of healthy returns as trauma procedures were not as impacted by the rise in the Delta variant as its elective procedure counterparts. The Trauma Market closed Q3 up +4.5% YoY compared to Q320, with the US up +5.8% YoY.

Among the many topics covered in detail in our comprehensive Q321 Trauma Market Recap* are:

Topics: Trauma